RecruitingNot ApplicableNCT06054165

Impact of a Clinical Pathway for Pelvic Fragility Fractures

Impact of Regional Implementation of a Clinical Pathway for ELderly Patients With pelVIc Fragility fraCtures (PELVIC); a Multicenter, Stepped-wedge Randomized Controlled Trial


Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Enrollment

393 participants

Start Date

Jan 21, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Patients with pelvic fragility fractures suffer from high morbidity and mortality rates. Despite the high incidence of these injuries, there is currently no regional or nationwide treatment protocol which results in a wide variety of clinical practice. New insights in treatment strategies, such as early diagnosis and minimal invasive operative treatment of these fragile patient population, has led to the development of several clinical pathways in recent literature. The aim of this study is to implement an evidence and experience-based treatment clinical pathway to improve the outcomes in this fragile patient population that currently has multifactorial risks for poor outcome.


Eligibility

Min Age: 50 Years

Inclusion Criteria2

  • Pelvic fragility fracture caused by low energetic trauma
  • Patients presented at the emergency room or out-patient clinic of a participating hospital

Exclusion Criteria6

  • Patients with high suspicion of a pelvic fracture due to a malignant tumor
  • Patients who are unable to follow instructions due to severe cognitive decline (for example due to dementia or Alzheimer's disease)
  • Patients who pre-trauma received palliative or terminal care
  • Patients who pre-trauma were wheelchair bound or bedridden
  • Patients who suffer from complications from previous pelvic ring fixation
  • Patients with insufficient comprehension of the Dutch language to be able to carry out the physiotherapy instructions for early mobilization

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERClinical pathway

Evidence-based and expert-opinion-based clinical pathway regarding the diagnostic and treatment strategy


Locations(8)

Flevoziekenhuis

Almere Stad, Flevoland, Netherlands

Noordwest Ziekenhuisgroep

Alkmaar, North Holland, Netherlands

BovenIJ ziekenhuis

Amsterdam, North Holland, Netherlands

OLVG

Amsterdam, North Holland, Netherlands

Amsterdam UMC

Amsterdam, North Holland, Netherlands

Spaarne Gasthuis

Haarlem, North Holland, Netherlands

Dijklander Ziekenhuis

Hoorn, North Holland, Netherlands

Zaans Medisch Centrum

Zaandam, North Holland, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06054165


Related Trials